id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2132455,84dadea6-e91a-41f2-bcf3-7d3511e699d6,Q1,BIOTECHNOLOGY INNOVATION ORGANIZATION,6245,BIOTECHNOLOGY INNOVATION ORGANIZATION,2018,first_quarter,MMM,"Medicaid
---Drug Benefit Design
---Pricing and Rebates
---Average Manufacturer Price Calculation

Reimbursement for Innovative Products
---Medicare Part B Physician-Administered Products
---Medicare Part D Prescription Drug Program
---S. 771: Improving Access to Affordable Prescription Drugs
---Third Party Support of Patient Premiums and Cost-Sharing Obligations
---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017
---Value-based Contracting and Communications
---CMS Hospital Inpatient Proposed Rule
---H.R. 242: Medicare Prescription Drug Price Negotiation Act
---H.R. 4138: Medicare Drug Price Negotiation Act
---H.R. 1892: Bipartisan Budget Act of 2018
---H.R. 1625: Consolidated Appropriations for FY 2018","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Natl Institutes of Health (NIH),Natl Security Council (NSC),Office of Management & Budget (OMB),Securities & Exchange Commission (SEC),SENATE,U.S. Trade Representative (USTR),White House Office",,2370000,0,0,2018-04-20T16:46:32.980000-04:00